Ipilimumab/Nivolumab Therapy in Patients With Metastatic Pancreatic or Biliary Cancer With Homologous Recombination Deficiency Pathogenic Germline Variants
Gretel Terrero, Jashodeep Datta, Jessica Dennison, Daniel A. Sussman, Ines Lohse, Nipun B. Merchant, Peter J. Hosein
Abstract
This case series describes ipilimumab/nivolumab therapy in patients with metastatic pancreatic or biliary cancer with homologous recombination deficiency (HRD) pathogenic germline variants (PGVs).
Topics & Concepts
MedicineFamily medicineOtorhinolaryngologyNeurologyMEDLINEInternal medicinePsychiatryPolitical scienceLawPancreatic and Hepatic Oncology ResearchNeuroendocrine Tumor Research AdvancesCancer Immunotherapy and Biomarkers